Abstract
BackgroundNemvaleukin alfa (nemvaleukin, ALKS 4230) is a novel, engineered cytokine that selectively binds to the intermediate-affinity interleukin-2 receptor, preferentially activating CD8+ T cells and natural killer cells, with minimal expansion...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have